JEFFREY FRANK BONADIO
Medical Practice in San Diego, CA
License number
Pennsylvania MD458746
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
San Diego, CA 92130
Pennsylvania
Pennsylvania
Professional information
Dr. Jeffrey F Bonadio, San Diego CA - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
4680 Tarantella Ln, San Diego 92130
(858) 525-1977 (Phone)
(858) 525-1977 (Phone)
Certifications:
Anatomic Pathology, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Medical College of Wisconsin
Graduated: 1979
Medical College of Wisconsin
Graduated: 1979
Methods Of Using Latent Tgf- Binding Proteins
US Patent:
6774105, Aug 10, 2004
Filed:
Jun 12, 2000
Appl. No.:
09/592685
Inventors:
Jeffrey Bonadio - San Diego CA
Wushan Yin - Ann Arbor MI
Wushan Yin - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
G01N 3353
US Classification:
514 12, 530350, 435 71
Abstract:
Disclosed are novel nucleic acid and peptide compositions comprising latent TGF binding proteins (LTBPs). Also disclosed are methods of using LTBP-2 and LTBP-3 peptides and the DNA segments which encode them.
Sustained Dna Delivery From Structural Matrices
US Patent:
7427602, Sep 23, 2008
Filed:
Nov 18, 1999
Appl. No.:
09/442542
Inventors:
Lonnie D. Shea - Evanston IL, US
Jeffrey Bonadio - San Diego CA, US
David J. Mooney - Ann Arbor MI, US
Martin C. Peters - Ann Arbor MI, US
Jeffrey Bonadio - San Diego CA, US
David J. Mooney - Ann Arbor MI, US
Martin C. Peters - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61N 43/04, A61K 63/00, A61K 9/14, A61K 45/00, A61F 13/00, C12P 21/06, C12N 15/00, C12N 5/00, A61K 38/00
US Classification:
514 44, 424 931, 424422, 424484, 424 851, 435 691, 4353201, 435325, 435455, 514 2, 514 54
Abstract:
Disclosed are particular 3-dimensional structural matrices containing nucleic acids, various fabrication processes and methods for the prolonged release of nucleic acids in various biological environments. The nucleic acid-matrix materials are created such that they maintain a defined space, allowing cellular migration, transfection and proliferation to occur in a controlled manner. The fabrication processes provide for both high incorporation efficiencies and control over the sustained nucleic acid release. The resultant nucleic acid-containing structural matrices are thus particularly useful in in vivo cell transfection and gene expression in the context of gene therapy.